Codexis, Inc. (CDXS) to Present at 2013 Biotechnology Industry Organization (BIO) International Convention
4/23/2013 6:37:57 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, announced today that Gjalt Huisman, Ph.D., Vice President, Pharmaceutical R&D at Codexis, will present at the 2013 BIO International Convention in Chicago, IL, on Tuesday, April 23, 2013. Dr. Huisman will present an overview of the company's application of its CodeEvolver® directed evolution technology platform in the field of enzyme therapeutics.
Help employers find you! Check out all the jobs and post your resume.